As 2024 draws to a close, several crucial developments — some aimed at modernizing long-standing legal practices, others addressing emerging challenges — have reached patent law.
Originally published in Law360 - December...more
12/23/2024
/ Administrative Procedure Act ,
Alice/Mayo ,
Appeals ,
Artificial Intelligence ,
Chevron Deference ,
Design Patent ,
Graham Factors ,
Intellectual Property Protection ,
International Trade Commission (ITC) ,
Inventions ,
Inventors ,
Loper Bright Enterprises v Raimondo ,
Obviousness ,
Patent Applications ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Rulemaking Process ,
SCOTUS ,
Statutory Interpretation ,
Tariff Act of 1930 ,
USPTO ,
Utility Patents
As a firm responsible for managing global portfolios for pharmaceutical companies, we closely follow and seek to stay abreast of developments regarding patentability in various jurisdictions. We recently reviewed the Unified...more
8/22/2024
/ Amgen v Sanofi ,
Corporate Counsel ,
Disclosure ,
Enablement Inquiries ,
Inventions ,
Patent Invalidity ,
Pharmaceutical Patents ,
Prior Art ,
Priority Patent Claims ,
Sanofi-Aventis ,
SCOTUS ,
Unified Patent Court
Following the U.S. Supreme Court’s invalidation of a counterpart U.S. patent in the same family for lack of enablement (21-757 Amgen Inc. v. Sanofi (05/18/23) (supremecourt.gov)), the UPC has now rendered a decision on its...more